Petros Pharmaceuticals, Inc. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Petros Pharmaceuticals, Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-12-31 was $0.00.
- Petros Pharmaceuticals, Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-09-30 was -$1.70M.
- Petros Pharmaceuticals, Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-06-30 was $90.00K.
- Petros Pharmaceuticals, Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-03-31 was $97.80K.
- Petros Pharmaceuticals, Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2021 was $187.80K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-31 | $187.80K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$1.70M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $90.00K 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $97.80K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |